Shanghai Yizhong Pharmaceutical (688091.SH): Shanghai Yixing plans to reduce its shareholding by no more than 1%

25/02/2025

GMT Eight

Shanghai Yizhong Pharmaceutical (688091.SH) announced that its shareholder Shanghai Yixing plans to reduce its total holdings of the company's shares by no more than 2,065,892 shares, or 1% of the company's total share capital, through centralized bidding transactions.

China Yuchai International Limited (CYD.US) reports a decline in revenue and profits in the second half of 2024, despite an increase in engine sales.

Guangzhou Ruoyuchen Technology's shareholder Lancy Co., Ltd. plans to reduce its shareholding by no more than 3%.

Contact: contact@gmteight.com

Shanghai Yizhong Pharmaceutical (688091.SH): Shanghai Yixing plans to reduce its shareholding by no more than 1%

RECOMMEND

US Stock Market Move | Chinese concept stocks rise against the market, KE Holdings, Inc. Sponsored ADR Class A (BEKE.US) up more than 6%

US Stock Market Move | New reasoning model QwQ released, Alibaba Group Holding Limited Sponsored ADR (BABA.US) rebounds against the trend by nearly 3%.

In February, consumer confidence in the United States fell sharply, marking the largest decline in four years.